- Home
- Companies
- australasia
- immune system
Show results for
Refine by
Immune System Suppliers In Australasia
14 companies found
based inMawson Lakes, AUSTRALIA
Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a ...
based inRobina, AUSTRALIA
Bionic Air Pty Ltd has a number of business streams. Sometimes these products inside the business streams will be great value for money, but sometimes we must make a decision on your behalf. Firstly, do we choose the cheaper products for you, or ...
A therapeutic registered medical device to replicate nature’s beneficial air species including Oxygen at a size small enough to be inhaled into the lungs and enter the bloodstream for repeatable biological benefits. The MKII provides you with ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta and Carina Biotech to develop next-generation i-body enabled CAR-T cancer therapeutics. AdAlta has entered a collaboration agreement with Carina Biotech to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-300-IV is being developed for the treatment of diabetic complications, including diabetic kidney disease known as diabetic ...
based inPaddington, AUSTRALIA
Regeneus is an Australian biotechnology company aiming to improve the quality of life of the hundreds of millions of patients worldwide suffering from long and short term pain. Pain and inflammation are responsible for a series of events leading to ...
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
The Cas9 endonuclease kit is part of an integrated solution for in-vitro CRISPR/Cas resesarch. Use this kit for in-vitro cloning of large genes or DNA fragments without the limitations imposed by common restriction enzymes or PCR fidelity. Allows ...
based inActon, AUSTRALIA
Lipotek is a developer of targeted vaccine delivery and adjuvant technologies. There is an undeniable need for technological solutions for prophylactic and therapeutic vaccination against pathogens, cancer and other diseases that have limited or no ...
based inBillerica, MASSACHUSETTS (USA)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists ...
based inCambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular nature of the antibody ...
based inRozelle, AUSTRALIA
Established in 2014, Revolution Surgical is a privately owned Australian medical and surgical device distributor. We are committed to providing the best devices to the Australian healthcare industry, whilst maintaining exceptional customer service. ...
SynvIchor™ is a revolutionary diagnostic device that is able to rapidly and reliably differentiate between infection and inflammation in a matter of hours. Every $1 spent on SynvIchor™ test will save the healthcare sector $25.21 in ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
based inPort Kembla, AUSTRALIA
Cenofex Innovations is a medical device startup company delivering unique solutions from the research lab into the hands of those that need it. Founded by a dynamic and passionate team, Cenofex Innovations is currently focused on the development of ...
Lymphoedema is a life-long, painful and incurable disease. Linked to a poorly functioning lymphatic system, it is characterised by a painful swelling of a limb or body region. Lymphoedema is most commonly caused by a removal of ...
based inKenmore, AUSTRALIA
Stance Global Pty Ltd provides the unique combination of skills and resources from Stance Environmental and Stance Agriculture. Stance Environmental provides skills and technologies for processing of waste and byproducts into products suitable for ...